Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma

Shenmiao Yang, Dong Dong, Hongfei Gu, Robert Peter Gale, Jun Ma, Xiaojun Huang
doi: https://doi.org/10.1101/2020.09.28.20203083
Shenmiao Yang
1Peking University Peoples Hospital, Peking University Institute of Hematology. National Clinical Research Center for Hematologic Disease, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong Dong
2JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, SAR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongfei Gu
3Chinese lymphoma patients organization, House086, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Peter Gale
4Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Ma
5Harbin Institute of Hematology & Oncology, Harbin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaojun Huang
1Peking University Peoples Hospital, Peking University Institute of Hematology. National Clinical Research Center for Hematologic Disease, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: huangxiaojun@bjmu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Back to top
PreviousNext
Posted September 29, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma
Shenmiao Yang, Dong Dong, Hongfei Gu, Robert Peter Gale, Jun Ma, Xiaojun Huang
medRxiv 2020.09.28.20203083; doi: https://doi.org/10.1101/2020.09.28.20203083
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma
Shenmiao Yang, Dong Dong, Hongfei Gu, Robert Peter Gale, Jun Ma, Xiaojun Huang
medRxiv 2020.09.28.20203083; doi: https://doi.org/10.1101/2020.09.28.20203083

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)